Lazard Asset Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-6,957
Closed -$387K 2034
2025
Q3
$387K Buy
6,957
+562
+9% +$30.1K ﹤0.01% 1429
2025
Q2
$329K Buy
+6,395
New +$321K ﹤0.01% 1595
2025
Q1
Sell
-16
Closed -$1K 2574
2024
Q4
$1K Hold
16
﹤0.01% 2241
2024
Q3
$1K Hold
16
﹤0.01% 2211
2024
Q2
$1K Buy
16
+8
+100% +$589 ﹤0.01% 2189
2024
Q1
$0 Hold
8
﹤0.01% 2367
2023
Q4
$0 Sell
8
-180
-96% -$11.9K ﹤0.01% 2463
2023
Q3
$12K Sell
188
-119
-39% -$9.4K ﹤0.01% 2138
2023
Q2
$24K Sell
307
-606
-66% -$48.7K ﹤0.01% 2071
2023
Q1
$66K Buy
913
+360
+65% +$27.7K ﹤0.01% 1699
2022
Q4
$45K Buy
553
+149
+37% +$11.8K ﹤0.01% 1879
2022
Q3
$28K Sell
404
-4,624
-92% -$400K ﹤0.01% 2002
2022
Q2
$435K Buy
5,028
+4,088
+435% +$383K ﹤0.01% 1148
2022
Q1
$101K Sell
940
-22,884
-96% -$2.36M ﹤0.01% 1392
2021
Q4
$3.08M Sell
23,824
-26,460
-53% -$3.24M ﹤0.01% 862
2021
Q3
$6.09M Sell
50,284
-5,432
-10% -$661K 0.01% 714
2021
Q2
$6.27M Buy
55,716
+41,848
+302% +$4.4M 0.01% 690
2021
Q1
$1.32M Buy
+13,868
New +$1.27M ﹤0.01% 855

Other funds holding TECH

Lazard Asset Management's TECH Position: Q4 2025 in Review

Lazard Asset Management sold out of Bio-Techne (TECH) in Q4 2025, closing a stake of 6,957 shares — an estimated $387K sold.

Lazard Asset Management first reported a position in TECH in Q1 2021 and held it in 18 quarters. The position peaked at $6.27M in Q2 2021. 584 funds tracked by Wall St. Rank hold TECH as of Q4 2025.

  • Lazard Asset Management reported no remaining Bio-Techne position as of Q4 2025 after selling out during the quarter.
  • Lazard Asset Management sold 6,957 Bio-Techne shares in Q4 2025, an estimated $387K.
  • Lazard Asset Management first reported a position in Bio-Techne in Q1 2021 and held it in 18 quarters.
  • Lazard Asset Management's Bio-Techne position peaked at $6.27M in Q2 2021.
  • 584 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2025.

Based on Lazard Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.